You are here
Standards, guidelines & publications (medical devices & IVDs)
Related information
2 August 2021
All medical devices marketed in Australia must meet the requirements which are set out in Chapter 4 of the Therapeutic Goods Act 1989, and in the Therapeutic Goods (Medical Devices) Regulations 2002.
- Australian regulatory guidelines for medical devices (ARGMD)
Regulatory requirements for medical devices in Australia - IVD guidance documents
Regulatory requirements for in vitro diagnostic medical devices (IVDs) - Clinical evidence guidelines documents for medical devices
Guidance on what constitutes clinical evidence and the process of clinical data generation and clinical evaluation to produce such clinical evidence - Conformity assessment
Guidance for conformity assessment applications, including changes to TGA issued conformity assessment certificates - Medical device application processing times
Information on time taken to process 75% and 90% of conformity assessment applications and applications for inclusion on the ARTG
Related guidance and standards
A
- Advice for health procurement teams about therapeutic goods and medical devices
Guidance for procurement areas in hospitals, aged care residential facilities and other facilities - Application requirements for medical devices - preliminary assessment
Applications for the inclusion of medical devices (including IVDs) in the ARTG must meet certain requirements in order to pass preliminary assessment
C
- Chlamydia, gonorrhoea and syphilis IVD self-tests
Guidance on TGA's expectations concerning performance requirements and risk mitigations for IVDs intended to be used as self-tests for chlamydia, gonorrhoea and syphilis - Clinical evidence guidelines supplement: In vitro diagnostic (IVD) medical devices
Guidance to assist sponsors of IVDs with clinical evidence - Clinical performance requirements and risk mitigation strategies for HIV tests
Guidance document for manufacturers and sponsors of HIV tests - Comparable overseas regulators for medical device applications
Use of market authorisation evidence from comparable overseas regulators for medical devices - Conditions of approval on the ARTG for HIV POCT
Information on conditions of approval on the ARTG for HIV POCT - Custom made medical devices
Manufacturing of custom made devices must, at a minimum, meet conformity assessment procedures regulated by the TGA - Cyber security for medical devices and IVDs
Cybersecurity is an important consideration for medical devices and IVD medical devices (IVDs)
D
- Declaration of Conformity for Class I non-sterile non-measuring and Class 1 in vitro diagnostic (IVD) medical devices
Declaration of Conformity procedures for Class I medical devices and Class 1 IVDs - Defining joint replacement medical devices and ancillary medical devices
Regulatory amendments defining shoulder, hip and knee joint replacement medical devices and ancillary medical devices - Device-medicine boundary products
This document is currently under review
E
- Electronic Instructions for Use - eIFU
Guidance for manufacturers of medical devices who may be considering supplying the instructions for use of their device in an electronic or online format
H
- Hepatitis B and C viruses IVD self-tests
Guidance on TGA's expectations concerning clinical performance requirements and risk mitigations for IVDs intended to be used as self-tests for Hepatitis B and C viruses - How to determine if your product should be included in the ARTG
Assistance for sponsors with products included in the ARTG as Class I medical devices to decide if their products are included correctly
I
- In vitro fertilisation (IVF) solutions
Summarises requirements for IVF solutions to demonstrate compliance with the Essential Principles for safety and performance of medical devices, or the Australian Medical Device Requirements (DR4, for devices containing material of human origin)
L
- Labelling obligations
This information explains the labelling requirements for medical devices to help manufacturers and sponsors meet their obligations
M
- Medical Device Incident Reporting (MDIR) guide
Sponsor guide to MDIR 2019 - Medical device patient cards and leaflets
Guidance explaining the requirements for the patient implant cards and patient information leaflets for manufacturers of medical devices
O
- Off-label use of medical devices: Frequently asked questions
Answers to frequently asked questions about off-label use of medical devices.
P
- The Poisons Standard and medical devices
Guidance explaining the labelling requirements of medical devices containing poisons - Priority applicant guidelines for medical devices (including IVDs)
Guidelines to assist applicants seeking a conformity assessment (priority applicant) determination or a medical devices (priority applicant) determination
R
- Regulation of borderline disinfectants and related products with antiviral claims (including COVID-19)
Information for sponsors and manufacturers - Reclassification of surgical mesh devices
Guidance to assist sponsors with the reclassification of surgical mesh devices - Reduction of assessment fees for medical devices
Eligibility requirements and procedures to determine whether assessment fees can be reduced - Regulation of Software as a Medical Device
Updated information on the regulation of Software as a Medical Device - Requirements for the assessment of medical devices containing animal material
Requirements with particular regard to the minimisation of risks relating to transmitting transmissible spongiform encephalopathies (TSEs)
S
- Seasonal Influenza IVD self-tests
Guidance on TGA's expectations concerning clinical performance requirements and risk mitigation for IVDs intended to be used as self-tests for seasonal influenza - Specimen collection swabs
All collection swabs are medical devices, and must be included in the ARTG - Standards orders and medical devices
Non-mandatory medical device standards orders (MDSO) and conformity assessment standards orders (CASO)
T
- TGA-NATA MoU relating to the regulation of in-house IVDs
This MoU describes the interaction, role and responsibilities of the TGA and NATA in relation to the regulation of in-house IVDs - 3-D printing (additive manufacturing) of medical devices
Information for manufacturers to assist them with addressing risks and meeting the Australian regulatory requirements for medical devices
V
- Varying entries in the ARTG - medical devices and IVDs
New guidance available